Applied DNA Sciences (APDN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Applied DNA Sciences Revenue Highlights


Latest Revenue (Y)

$3.43M

Latest Revenue (Q)

$983.37K

Main Segment (Y)

Clinical Laboratory Testing Services (Over-Time)

Main Geography (Y)

Americas

Applied DNA Sciences Revenue by Period


Applied DNA Sciences Revenue by Year

DateRevenueChange
2024-09-30$3.43M-74.33%
2023-09-30$13.37M-26.43%
2022-09-30$18.17M101.25%
2021-09-30$9.03M367.40%
2020-09-30$1.93M-64.16%
2019-09-30$5.39M38.06%
2018-09-30$3.90M-17.85%
2017-09-30$4.75M13.49%
2016-09-30$4.19M-53.53%
2015-09-30$9.01M231.05%
2014-09-30$2.72M33.64%
2013-09-30$2.04M9.79%
2012-09-30$1.85M91.43%
2011-09-30$968.85K86.37%
2010-09-30$519.84K76.12%
2009-09-30$295.16K-66.19%
2008-09-30$873.01K616.05%
2007-09-30$121.92K545.08%
2006-09-30$18.90K100.00%
2005-09-30-100.00%
2004-09-30-100.00%
2003-09-30-100.00%
2001-12-31-100.00%
2000-12-31-100.00%
1999-12-31-100.00%
1998-12-31-100.00%
1997-12-31--

Applied DNA Sciences generated $3.43M in revenue during NA 2024, up -74.33% compared to the previous quarter, and up 63.67% compared to the same period a year ago.

Applied DNA Sciences Revenue by Quarter

DateRevenueChange
2025-03-31$983.37K-17.82%
2024-12-31$1.20M47.17%
2024-09-30$813.11K1.95%
2024-06-30$797.52K-14.21%
2024-03-31$929.63K4.32%
2023-12-31$891.16K14.29%
2023-09-30$779.74K-73.27%
2023-06-30$2.92M-33.81%
2023-03-31$4.41M-16.25%
2022-12-31$5.26M47.86%
2022-09-30$3.56M-17.16%
2022-06-30$4.30M-30.11%
2022-03-31$6.15M47.57%
2021-12-31$4.17M37.04%
2021-09-30$3.04M78.77%
2021-06-30$1.70M-36.35%
2021-03-31$2.67M65.30%
2020-12-31$1.62M414.71%
2020-09-30$313.99K-27.24%
2020-06-30$431.52K-21.89%
2020-03-31$552.47K-12.79%
2019-12-31$633.52K-62.13%
2019-09-30$1.67M-18.54%
2019-06-30$2.05M163.78%
2019-03-31$778.47K-11.97%
2018-12-31$884.32K-26.02%
2018-09-30$1.20M17.61%
2018-06-30$1.02M-2.64%
2018-03-31$1.04M61.18%
2017-12-31$647.68K-43.46%
2017-09-30$1.15M-36.27%
2017-06-30$1.80M98.52%
2017-03-31$905.37K0.26%
2016-12-31$903.01K-44.81%
2016-09-30$1.64M150.59%
2016-06-30$652.90K13.88%
2016-03-31$573.32K-56.70%
2015-12-31$1.32M-66.73%
2015-09-30$3.98M75.52%
2015-06-30$2.27M49.31%
2015-03-31$1.52M22.30%
2014-12-31$1.24M92.37%
2014-09-30$645.53K-23.26%
2014-06-30$841.20K32.03%
2014-03-31$637.15K6.66%
2013-12-31$597.35K-18.07%
2013-09-30$729.11K13.07%
2013-06-30$644.84K87.12%
2013-03-31$344.61K8.48%
2012-12-31$317.67K9.23%
2012-09-30$290.81K-44.98%
2012-06-30$528.57K1.96%
2012-03-31$518.40K0.29%
2011-12-31$516.90K84.03%
2011-09-30$280.88K22.28%
2011-06-30$229.71K63.56%
2011-03-31$140.44K-55.81%
2010-12-31$317.82K254.47%
2010-09-30$89.66K-47.32%
2010-06-30$170.19K-9.12%
2010-03-31$187.28K157.55%
2009-12-31$72.72K19.22%
2009-09-30$60.99K166.05%
2009-06-30$22.93K-64.55%
2009-03-31$64.67K-55.88%
2008-12-31$146.57K-49.35%
2008-09-30$289.42K14.53%
2008-06-30$252.69K-
2008-03-31$252.69K-

Applied DNA Sciences generated $983.37K in revenue during Q2 2025, up -17.82% compared to the previous quarter, and up 110.35% compared to the same period a year ago.

Applied DNA Sciences Revenue Breakdown


Applied DNA Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 24Sep 23Sep 22Sep 21Sep 20
Clinical Laboratory Testing Services (Point-in-Time)$32.61K$7.61M---
Supply Chain$1.21M$827.60K$38.58K--
Asset Marking$9.44K$311.81K$400.49K--
Clinical Laboratory Testing Services (Over-Time)$1.29M$3.54M---
Research and Development Services (Over-Time)$311.24K$421.58K---
Large Scale DNA Production$584.12K$653.01K---
Asset marking--$534.59K$458.41K-
Research and development services (over-time)--$592.00K$799.72K-
Supply chain--$887.06K$1.00M-
Clinical laboratory testing services (point-in-time)--$10.40M$4.79M-
Clinical laboratory testing services (over-time)--$5.13M--
Diagnostic kits---$1.97M-
Clinical Laboratory Testing Services----$81.95K
Research And Development Services----$1.13M
Large Scale Dna Production----$281.97K

Applied DNA Sciences's latest annual revenue breakdown by segment (product or service), as of Sep 24: Clinical Laboratory Testing Services (Over-Time) (37.46%), Supply Chain (35.22%), Large Scale DNA Production (17.02%), Research and Development Services (Over-Time) (9.07%), Clinical Laboratory Testing Services (Point-in-Time) (0.95%), and Asset Marking (0.28%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Large Scale DNA Production$333.66K$325.96K$258.15K-$271.88K$253.63K$127.51K-------------
Clinical Laboratory Testing Services (Over-Time)$220.55K$324.58K$636.16K$324.58K$324.58K$509.11K$653.38K$938.08K$1.44M-----------
Research and Development Services (Over-Time)$133.55K$147.44K$168.50K$65.20K$77.53K$72.00K$135.62K$87.91K$126.06K-----------
Supply Chain$290.23K$722.85K$465.95K$275.26K$467.49K$145.38K$242.83K$27.64K$411.76K$23.95K$67.06K$32.94K$2.90K$4.36K$12.65K-----
Asset Marking$5.38K-$9.44K$9.44K$39.03K$92.31K$97.34K$83.13K$113.72K$140.17K$151.76K$97.23K$83.53K$110.70K------
Clinical Laboratory Testing Services (Point-in-Time)$1.75K$1.75K$14.05K$6.44K$12.12K$14.22K$1.52M$3.00M$3.07M-----------
Clinical laboratory testing services (point-in-time)---------$1.69M$2.51M$4.33M$1.87M$1.64M------
Clinical laboratory testing services (over-time)---------$1.26M$1.39M$1.16M$1.33M-------
Asset marking---------$154.56K$127.08K$141.66K$105.52K$72.25K------
Research and development services (over-time)---------$119.46K$152.73K$219.90K$105.69K$213.43K------
Supply chain---------$316.81K$43.24K$115.46K$411.55K$879.30K------
Diagnostic test kits-----------$180.02K$342.82K-------
Diagnostic kits-------------$384.91K------
Equipment Lease Services Overtime--------------$43.96K$60.09K----
Clinical Laboratory Testing Services--------------$826.61K$1.55M$772.77K---
Diagnostic Kits--------------$494.27K$724.59K$394.96K---
Large Scale Dna Production-----------------$-1.00-$142.53K
Research And Development Services--------------$197.81K$124.76K$263.71K$131.91K$343.62K$286.60K
Product And Authentication Services--------------------

Applied DNA Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Large Scale DNA Production (33.87%), Supply Chain (29.46%), Clinical Laboratory Testing Services (Over-Time) (22.39%), Research and Development Services (Over-Time) (13.56%), Asset Marking (0.55%), and Clinical Laboratory Testing Services (Point-in-Time) (0.18%).

Applied DNA Sciences Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 24Sep 23Sep 22Sep 21Sep 20
Americas$2.27M$12.22M$17.54M--
Europe$172.37K$258.36K$448.85K$359.51K$266.70K
Asia and other$989.23K$886.44K$175.39K$147.89K-
United States---$8.52M-
U----$1.17M
Asia And Other----$499.48K

Applied DNA Sciences's latest annual revenue breakdown by geography, as of Sep 24: Americas (66.15%), Asia and other (28.83%), and Europe (5.02%).

Quarterly Revenue by Country

CountryDec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18Mar 18
Europe$69.24K$110.30K$117.71K$221.69K$150.67K$205.45K$228.41K$378.83K
U$393.49K$2.68M------
Asia And Other$170.79K$-1.12M$1.36M$221.75K$166.44K$52.77K$213.14K$433.72K
UNITED STATES--$580.25K$335.03K$567.22K$937.14K$574.80K$231.39K

Applied DNA Sciences's latest quarterly revenue breakdown by geography, as of Dec 19: U (62.11%), Asia And Other (26.96%), and Europe (10.93%).

Applied DNA Sciences Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
FONRFONAR$102.88B$2.02M
BNRBurning Rock Biotech$537.43M$125.62M
STIMNeuronetics$74.89M$22.49M
BDSXBiodesix$71.32M$20.43M
TRIBTrinity Biotech$56.83M$14.70M
XGNExagen$55.64M$15.50M
DRIODarioHealth$27.04M$7.60M
PREPrenetics Global$21.74M$6.41M
ISPCiSpecimen$9.29M$1.48M
APDNApplied DNA Sciences$3.43M$983.37K
OCXOncoCyte$1.88M$2.14M
MYNZMainz Biomed B.V.$895.48K$214.76K
SERASera Prognostics$77.00K$24.00K
PSNLPersonalis-$16.80M

APDN Revenue FAQ


What is Applied DNA Sciences’s yearly revenue?

Applied DNA Sciences's yearly revenue for 2024 was $3.43M, representing a decrease of -74.33% compared to 2023. The company's yearly revenue for 2023 was $13.37M, representing a decrease of -26.43% compared to 2022. APDN's yearly revenue for 2022 was $18.17M, representing an increase of 101.25% compared to 2021.

What is Applied DNA Sciences’s quarterly revenue?

Applied DNA Sciences's quarterly revenue for Q2 2025 was $983.37K, a -17.82% decrease from the previous quarter (Q1 2025), and a 5.78% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $1.2M, a 47.17% increase from the previous quarter (Q4 2024), and a 34.28% increase year-over-year (Q1 2024). APDN's quarterly revenue for Q4 2024 was $813.11K, a 1.95% increase from the previous quarter (Q3 2024), and a 4.28% increase year-over-year (Q4 2023).

What is Applied DNA Sciences’s revenue growth rate?

Applied DNA Sciences's revenue growth rate for the last 3 years (2022-2024) was -81.11%, and for the last 5 years (2020-2024) was 77.66%.

What are Applied DNA Sciences’s revenue streams?

Applied DNA Sciences's revenue streams in p 24 are Clinical Laboratory Testing Services (Point-in-Time), Supply Chain, Asset Marking, Clinical Laboratory Testing Services (Over-Time), Research and Development Services (Over-Time), and Large Scale DNA Production. Clinical Laboratory Testing Services (Point-in-Time) generated $32.61K in revenue, accounting 0.95% of the company's total revenue, down -99.57% year-over-year. Supply Chain generated $1.21M in revenue, accounting 35.22% of the company's total revenue, up 46.05% year-over-year. Asset Marking generated $9.44K in revenue, accounting 0.28% of the company's total revenue, down -96.97% year-over-year. Clinical Laboratory Testing Services (Over-Time) generated $1.29M in revenue, accounting 37.46% of the company's total revenue, down -63.70% year-over-year. Research and Development Services (Over-Time) generated $311.24K in revenue, accounting 9.07% of the company's total revenue, down -26.17% year-over-year. Large Scale DNA Production generated $584.12K in revenue, accounting 17.02% of the company's total revenue, down -10.55% year-over-year.

What is Applied DNA Sciences’s main source of revenue?

For the fiscal year ending Sep 24, the largest source of revenue of Applied DNA Sciences was Clinical Laboratory Testing Services (Over-Time). This segment made a revenue of $1.29M, representing 37.46% of the company's total revenue.